Clinical characteristics and quality of life in Chinese patients with Parkinson’s disease beyond 20 years

References

• Morgante L, Salemi G, Meneghini F, et al. Parkinson disease survival: a population-based study. Arch Neurol. 2000;57:507–512.10.1001/archneur.57.4.507
   PubMedGoogle Scholar
• Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442.10.1212/WNL.17.5.427
   PubMed Web of Science ®Google Scholar
• Lees AJ, Hardy J, Revesz T. Parkinson’s disease. Lancet (London, England) 2009;373:2055–2066.10.1016/S0140-6736(09)60492-X
   Google Scholar
• Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. What predicts mortality in Parkinson disease?: A prospective population-based long-term study. Neurology. 2010;75:1270–1276.10.1212/WNL.0b013e3181f61311
   PubMed Web of Science ®Google Scholar
• Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord Off J Mov Disord Soc. 2008;23:837–844.10.1002/mds.21956
   PubMed Web of Science ®Google Scholar
• Castrioto A, Lozano AM, Poon YY, et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol. 2011;68:1550–1556.10.1001/archneurol.2011.182
   PubMed Web of Science ®Google Scholar
• Hassan A, Wu SS, Schmidt P, et al. The profile of long-term Parkinson’s disease survivors with 20 years of disease duration and beyond. J Parkinson's Dis. 2015;5:313–319.10.3233/JPD-140515
   PubMedGoogle Scholar
• Cilia R, Cereda E, Klersy C, et al. Parkinson’s disease beyond 20 years. J Neurol Neurosurg Psychiatry. 2015;86:849–855.10.1136/jnnp-2014-308786
   PubMed Web of Science ®Google Scholar
• Munhoz RP, Espay AJ, Morgante F, et al. Long-duration Parkinson's disease: role of lateralization of motor features. Parkinsonism Relat Disord. 2013;19:77–80.10.1016/j.parkreldis.2012.07.008
   PubMed Web of Science ®Google Scholar
• Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184.10.1136/jnnp.55.3.181
   PubMed Web of Science ®Google Scholar
• Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2010;25:2649–2653.10.1002/mds.23429
   PubMed Web of Science ®Google Scholar
• Goetz CG, Tilley BC, Shaftman SR, et al. Movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–2170.10.1002/mds.v23:15
   PubMed Web of Science ®Google Scholar
• Mahieux F, Michelet D, Manifacier MJ, et al. Mini-mental Parkinson: first validation study of a new bedside test constructed for Parkinson’s disease. Behav Neurol. 1995;8:15–22.10.1155/1995/304876
   PubMed Web of Science ®Google Scholar
• Wang G, Hong Z, Cheng Q, et al. Validation of the Chinese non-motor symptoms scale for Parkinson's disease: results from a Chinese pilot study. Clin Neurol Neurosurg. 2009;111:523–526.10.1016/j.clineuro.2009.02.005
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26:353–357.10.1093/ageing/26.5.353
   PubMed Web of Science ®Google Scholar
• Zis P, Rizos A, Martinez-Martin P, et al. Non-motor symptoms profile and burden in drug naive versus long-term Parkinson’s disease patients. J Parkinson’s Dis. 2014;4:541–547.
   PubMedGoogle Scholar
• Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.10.1016/S0197-4580(02)00065-9
   PubMed Web of Science ®Google Scholar
• Grinberg LT, Rueb U, Alho AT, et al. Brainstem pathology and non-motor symptoms in PD. J Neurol Sci. 2010;289:81–88.10.1016/j.jns.2009.08.021
   PubMed Web of Science ®Google Scholar
• Diederich NJ, Moore CG, Leurgans SE, et al. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003;60:529–533.10.1001/archneur.60.4.529
   PubMedGoogle Scholar
• Diamond SG, Markham CH, Hoehn MM, et al. Effect of age at onset on progression and mortality in Parkinson’s disease. Neurology. 1989;39:1187–1190.10.1212/WNL.39.9.1187
   PubMed Web of Science ®Google Scholar
• Gomez Arevalo G, Jorge R, Garcia S, et al. Clinical and pharmacological differences in early- versus late-onset Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 1997;12:277–284.10.1002/(ISSN)1531-8257
   PubMed Web of Science ®Google Scholar
• Denny AP, Behari M. Motor fluctuations in Parkinson’s disease. J Neurol Sci. 1999;165:18–23.10.1016/S0022-510X(99)00052-0
   PubMed Web of Science ®Google Scholar
• Kempster PA, O’Sullivan SS, Holton JL, et al. Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain J Neurol. 2010;133:1755–1762.10.1093/brain/awq059
   Google Scholar
• Kim JB, Kim BJ, Koh SB, et al. Autonomic dysfunction according to disease progression in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:303–307.10.1016/j.parkreldis.2013.12.001
   PubMed Web of Science ®Google Scholar
• Liu B, Fang F, Pedersen NL, et al. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88:1996–2002.10.1212/WNL.0000000000003961
   PubMed Web of Science ®Google Scholar
• Song W, Guo X, Chen K, et al. The impact of non-motor symptoms on the health-related quality of life of Parkinson’s disease patients from Southwest China. Parkinsonism Relat Disord. 2014;20:149–152.10.1016/j.parkreldis.2013.10.005
   PubMed Web of Science ®Google Scholar
• Hinnell C, Hurt CS, Landau S, et al. Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease? Mov Disord Off J Mov Disord Soc. 2012;27:236–241.10.1002/mds.23961
   PubMed Web of Science ®Google Scholar
• Shearer J, Green C, Counsell CE, et al. The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson’s disease. J Neurol. 2012;259:462–468.10.1007/s00415-011-6202-y
   PubMed Web of Science ®Google Scholar
• Qin Z, Zhang L, Sun F, et al. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord. 2009;15:767–771.10.1016/j.parkreldis.2009.05.011
   PubMed Web of Science ®Google Scholar